Clinical decision support
The partnership with the Joslin Diabetes Center will add a panel of novel biomarkers to the indicators currently captured by KidneyIntelX.
The system identifies potentially dangerous lesions during colonoscopies – but is not intended to diagnose or instruct on next steps.
Although diagnostic accuracy improved, triage accuracy and anxiety levels remained unchanged from before and after the internet search.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.